Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-4-1
pubmed:abstractText
Recently, we reported that lysophosphatidic acid (LPA) induces long-lasting mechanical allodynia and thermal hyperalgesia as well as demyelination and upregulation of pain-related proteins through one of its cognate receptors, LPA1. In addition, mice lacking the LPA1 receptor gene (lpa1-/- mice) lost these nerve injury-induced neuropathic pain behaviors and phenomena. However, since lpa1-/- mice did not exhibit any effects on the basal nociceptive threshold, it is possible that nerve injury-induced neuropathic pain and its machineries are initiated by LPA via defined biosynthetic pathways that involve multiple enzymes. Here, we attempted to clarify the involvement of a single synthetic enzyme of LPA known as autotaxin (ATX) in nerve injury-induced neuropathic pain. Wild-type mice with partial sciatic nerve injury showed robust mechanical allodynia starting from day 3 after the nerve injury and persisting for at least 14 days, along with thermal hyperalgesia. On the other hand, heterozygous mutant mice for the autotaxin gene (atx+/-), which have 50% ATX protein and 50% lysophospholipase D activity compared with wild-type mice, showed approximately 50% recovery of nerve injury-induced neuropathic pain. In addition, hypersensitization of myelinated Abeta or Adelta-fiber function following nerve injury was observed in electrical stimuli-induced paw withdrawal tests using a Neurometer. The hyperalgesia was completely abolished in lpa1-/- mice, and reduced by 50% in atx+/- mice. Taken together, these findings suggest that LPA biosynthesis through ATX is the source of LPA for LPA1 receptor-mediated neuropathic pain. Therefore, targeted inhibition of ATX-mediated LPA biosynthesis as well as LPA1 receptor and its downstream pathways may represent a novel way to prevent nerve injury-induced neuropathic pain.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-11087622, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-11087877, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-12119361, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-12176993, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-12510192, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-12604668, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-12716929, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-1383223, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-14500380, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-15195086, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-15271293, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-15686493, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-16681855, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-16687474, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-16829511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-17459484, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-18280050, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-3340425, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-6877845, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-7684247, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-8675684, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-9422033, http://linkedlifedata.com/resource/pubmed/commentcorrection/18261210-9696476
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1744-8069
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
pubmed:affiliation
Division of Molecular Pharmacology and Neuroscience, Nagasaki University, Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan. minoue@nagasaki-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural